Skip to main content
Top
Published in: Breast Cancer 4/2015

Open Access 01-07-2015 | Case Report

Ductal carcinoma in situ arising in tubular adenoma of the breast

Authors: Michiyo Saimura, Keisei Anan, Shoshu Mitsuyama, Minoru Ono, Satoshi Toyoshima

Published in: Breast Cancer | Issue 4/2015

Login to get access

Abstract

We herein report an extremely rare case of ductal carcinoma in situ (DCIS) arising in tubular adenoma of the breast. A 33-year-old female first noticed a mass in her right breast when she was 15 years old. The tumor had not changed in size subjectively for 18 years. She finally visited the hospital one and a half years before this presentation for an examination of her breast mass. Ultrasonography (US) showed a circumscribed mass suggesting a benign tumor, and mammography (MMG) revealed the well-defined high-density mass with a focal region of microcalcification. It was suspected to be adenosis based on a core-needle biopsy (CNB). During the regular follow-up, the microcalcification in the mass increased. She was therefore referred to our hospital for further examination. US and MMG showed a well-demarcated mass with a focal microcalcified area. US-guided CNB diagnosed it as DCIS with tubular adenoma. The patient underwent tumorectomy. Histologically, the tumor was diagnosed to be DCIS in tubular adenoma with negative surgical margins.
Literature
1.
go back to reference Persaud V, Talerman A, Jordan R. Pure adenoma of the breast. Arch Path. 1968;86:481–3.PubMed Persaud V, Talerman A, Jordan R. Pure adenoma of the breast. Arch Path. 1968;86:481–3.PubMed
3.
go back to reference Rosen PP, Overman HA. Benign epithelial lesions. In: Rosai J (ed) Atlas of tumor pathology, 3rd series. Tumors of the mammary gland, vol. 7. Washington DC: Armed Forces Institute of Pathology; 1992. p. 67–100. Rosen PP, Overman HA. Benign epithelial lesions. In: Rosai J (ed) Atlas of tumor pathology, 3rd series. Tumors of the mammary gland, vol. 7. Washington DC: Armed Forces Institute of Pathology; 1992. p. 67–100.
4.
go back to reference Bellocq JP, Magro G. Fibroepithelial tumors. In: Tavassoli FA, Devilee P (eds) World Health Organization classification of tumor. Pathology and genetics of tumors of the breast and female genital organs. Lyon: IARC Press; 2003. p. 84. Bellocq JP, Magro G. Fibroepithelial tumors. In: Tavassoli FA, Devilee P (eds) World Health Organization classification of tumor. Pathology and genetics of tumors of the breast and female genital organs. Lyon: IARC Press; 2003. p. 84.
5.
go back to reference Nielsen BB. Adenosis tumor of the breast—a clinicopathological investigation of 27 cases. Histopathology. 1987;11:1259–75.PubMedCrossRef Nielsen BB. Adenosis tumor of the breast—a clinicopathological investigation of 27 cases. Histopathology. 1987;11:1259–75.PubMedCrossRef
6.
go back to reference Hill RP, Miller FN. Adenomas of the breast. With case report of carcinomatous transformation in an adenoma. Cancer. 1954;7:318–24.PubMedCrossRef Hill RP, Miller FN. Adenomas of the breast. With case report of carcinomatous transformation in an adenoma. Cancer. 1954;7:318–24.PubMedCrossRef
7.
go back to reference Case TC. Adenocarcinoma of breast arising in adenoma. N Y State J Med. 1977;77:2122–3.PubMed Case TC. Adenocarcinoma of breast arising in adenoma. N Y State J Med. 1977;77:2122–3.PubMed
8.
go back to reference Domoto H, Tsuda H, Miyakawa K, Shinoda A, Nanasawa T. Invasive ductal carcinoma associated with tubular adenoma of the breast. Pathol Int. 2002;52:244–8.PubMedCrossRef Domoto H, Tsuda H, Miyakawa K, Shinoda A, Nanasawa T. Invasive ductal carcinoma associated with tubular adenoma of the breast. Pathol Int. 2002;52:244–8.PubMedCrossRef
Metadata
Title
Ductal carcinoma in situ arising in tubular adenoma of the breast
Authors
Michiyo Saimura
Keisei Anan
Shoshu Mitsuyama
Minoru Ono
Satoshi Toyoshima
Publication date
01-07-2015
Publisher
Springer Japan
Published in
Breast Cancer / Issue 4/2015
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-012-0375-9

Other articles of this Issue 4/2015

Breast Cancer 4/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine